Citation: | LI Yu-juan, SUI Ying-jie, XIN Nian. Pharmacokinetic Study and Tissue Distribution of Single Mangiferin After Intravenous Administration in Rats[J].JOURNAL OF BEIJING INSTITUTE OF TECHNOLOGY, 2009, 18(1): 89-93. |
[1] |
State Pharmacopoeia Commission of the Peoples Republic of China. Pharmacopoeia of the People’s Republic of China, Vol.1[M]. Beijing: Chemical Industry Press, 2005:148. (in Chinese)
|
[2] |
Jiang J, Li M, Xiang J Z. Effect of chinonin against influenza virus . China Pharmacist, 2004, 75: 335-338. (in Chinese)
|
[3] |
Deng J G, Zheng Z W, Zeng C H. Pharmacodynamic studies on mangiferin . Chinese Archives of Traditional Chinese Medicine, 2002, 20:802-803. (in Chinese)
|
[4] |
Yoosook C, Bunyapraphatsara N, Boonyakiat Y, et al. Anti-herpes simplex virus activities of crude water extracts of Thaimedici nalplants[J]. Plytomedicine, 2000, 6:411-414.
|
[5] |
Ichiki H, Miura T, Ishihara E, et al. New C compounds, mangiferin and its glucoside[J]. Biol Pharm Bull, 1998, 21:1389-1392.
|
[6] |
Yoshimi N, Matsunaga K, Katayama M, et al. The inhibitory effects of mangiferin, a naturally occurring glucosylxanthone, in bowel carcinogenesis of male F344 rats[J]. Cancer Lett, 2001, 163:163-166.
|
[7] |
Lai L, Lin L C, Lin J H, et al. Pharmacokinetic study of free mangiferin in rats by microdialysis coupled with microbore high-performance liquid chromatography and tandem mass spectrometry[J]. J Chromatogr A, 2003, 987:367-374.
|
[8] |
Li Y J, Sui Y J, Dai Y H, et al. LC determination and pharmacokinetics study of mangiferin in rat plasma and tissues[J]. Chromatographia, 2008, 67: 957-960.
|
[9] |
Vinod P S, Kamol K M, Shrikant D, et al. Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies[J]. J Pharm Sci, 1992, 81:309-312. (Edited by
|